GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

Currently, we are focused on the hepatitis B virus capsid, the cytoplasmic dynein motor domain, and the role of carbohydrates and glycoconjugates in immunity and disease. "Assembly properties of ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

Unlike inactivated, subunit or recombinant protein vaccines (such as those against diphtheria, pertussis, tetanus, hepatitis B virus and flu ... for the capsid protein P1, was recoded with ...